Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 1294 entries
View as:

Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01076842 Org: User:
Start: 04/30/08 End: 04/30/11 Due: 04/30/12

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00709917 Org: User:
Start: 03/31/07 End: 01/31/08 Due: 01/31/09

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05316662 Org: User:
Start: 04/06/22 End: 04/09/24 Due: 04/09/25

An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00698269 Org: User:
Start: 02/29/08 End: 08/31/09 Due: 08/31/10

Investigation of the Response Relationship of NN5401 in Type 1 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00993096 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01507285 Org: User:
Start: 08/31/99 End: 11/30/99 Due: 11/30/00

A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00961324 Org: User:
Start: 07/27/09 End: 10/26/09 Due: 10/26/10

The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02008682 Org: User:
Start: 12/31/13 End: 11/30/14 Due: 11/30/15

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00704223 Org: User:
Start: 05/31/08 End: 11/30/08 Due: 11/30/09

A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT01959529 Org: User:
Start: 10/29/13 End: 10/16/16 Due: 10/16/17

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Phase: N/A Priority: Normal
NCT ID: NCT04795531 Org: User:
Start: 03/24/21 End: 06/23/22 Due: 06/23/23

An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00789711 Org: User:
Start: 11/30/08 End: 08/31/09 Due: 08/31/10

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01527565 Org: User:
Start: 01/20/03 End: 02/26/03 Due: 02/26/04

Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01486888 Org: User:
Start: 05/31/06 End: 07/31/06 Due: 07/31/07

An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01846312 Org: User:
Start: 05/31/13 End: 09/30/15 Due: 09/30/16

A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight

Phase: N/A Priority: Normal
NCT ID: NCT06289504 Org: User:
Start: 02/27/24 End: 11/15/24 Due: 11/15/25

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01527630 Org: User:
Start: 11/16/02 End: 01/08/03 Due: 01/08/04

Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00097279 Org: User:
Start: 08/31/04 End: 08/31/05 Due: 08/31/06

A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men

Phase: N/A Priority: Normal
NCT ID: NCT04722653 Org: User:
Start: 02/02/21 End: 04/27/21 Due: 04/27/22

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Phase: N/A Priority: Normal
NCT ID: NCT06118281 Org: User:
Start: 06/25/24 End: 09/03/26 Due: 09/03/27

A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03407599 Org: User:
Start: 01/08/18 End: 07/05/18 Due: 07/05/19

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea

Phase: N/A Priority: Normal
NCT ID: NCT01557166 Org: User:
Start: 06/07/12 End: 06/17/13 Due: 06/17/14

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00706017 Org: User:
Start: 09/30/07 End: 07/31/08 Due: 07/31/09

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00410033 Org: User:
Start: 12/31/89 End: 05/31/06 Due: 05/31/07

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT05405114 Org: User:
Start: 07/07/22 End: 08/27/25 Due: 08/27/26